Drug intelligence / Profile preview

Lactiferon Plus

Development stage: Unknown
Lead developer: Meditrina Pharmaceuticals
Modality: Small Molecules, Recombinant Proteins and Enzymes
Administration: Oral

Overview

Lactiferon Plus is a multi-ingredient dietary supplement developed by MEDITRINA Pharmaceuticals, specifically formulated for gynecological health, including support during pregnancy and breastfeeding. It contains a combination of lactoferrin, ferrous bisglycinate (a highly bioavailable iron chelate), L-methyltetrahydrofolic acid (the active form of folate), ascorbic acid, beta-carotene, and methylcobalamin. The product is designed to restore iron homeostasis, support the immune system, and provide essential micronutrients. It is delivered as gastro-resistant tablets to ensure the release of ingredients in the intestine for optimal absorption and reduced gastrointestinal side effects.

Brand names: Lactiferon Plus

Targets

LTF (Lactoferrin)

Beyond the preview

Go deeper on Lactiferon Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactiferon Plus.

Explore the full profile